arGEN-X advances a third therapeutic antibody program into preclinical development: http://t.co/hBB8aUOQ
posted 17 hours ago
FlandersBio informs you about important regional and national life sciences news. Send us your news. If your news is of interest to the life sciences community, we will post it on our website.
FUGEIA NV kondigt vandaag aan dat het een Europese goedkeuring heeft verkregen voor Brana Vita[TM]als "Novel Food" of nieuw voedingsingrediënt. Brana Vita[TM] is een natuurlijk voedingsingrediënt dat rijk is aan arabinoxylan-oligosacchariden (AXOS). Dit zijn oplosbare vezels uit de celwand van tarwezemelen. De AXOS in Brana Vita[TM] hebben een sterke prebiotische werking, ze stimuleren m.a.w. de groei van goede bacteriën (zoals bifidobacteriën) in de dikke darm. Bovendien hebben ze ook een sterke antioxidant werking omwille van de polyfenolen die eraan gebonden zijn. read more
Opening of new laboratories on the Waterfront science park in Niel, Belgium Multiplicom nv, specialized in the development, production and commercialization of innovative molecular genetic tests, announces that it launches two new kits for cancer predisposition screening based on its Multiplexer™-technology. Concurrently the company will on September 23rd officially open its brand new laboratories on the Waterfront science park in Niel, Belgium. read more
Clinici beschikken voortaan over een nieuw hulpmiddel bij het stellen van een diagnose en het behandelen van patiënten besmet met het Herpes simplex-virus (HSV) – één van de meest gangbare seksueel overdraagbare aandoeningen ter wereld. read more
BD Biosciences, een onderdeel van BD (Becton, Dickinson and Company), heeft vandaag de BD FACSVerse™-flowcytometer geïntroduceerd. Dit is een flexibel, betrouwbaar en schaalbaar systeem dat maximaal 10 parameters kan analyseren en voor een groot aantal onderzoekstoepassingen kan worden gebruikt. read more
ThromboGenics NV (Euronext Brussels: THR), a biopharmaceutical company focused on developing innovative ophthalmic medicines, today issued an update on its filing plans and pre-commercialization activities for its lead product ocriplasmin. read more
Peira is one of the companies that participates in the Belgian Economic Mission to the US and puts two new developments, designed in Flanders-Belgium, on display at the Bio 2011 International Convention. The Bio Convention is one of the largest events for companies and research organisations active in life sciences/biotechnoloy. The Belgian booth will host more than 60 Belgian companies active in the field. The Flemish representation at the convention is organised by FlandersBio, the cluster organisation for the biotech sector in Flanders, and FIT. This year the Pavilion will be inaugurated by H.R.H. Prince Philippe on Tuesday 28 June 2011. read more
Applied Maths today announces that Bayer CropScience has decided to implement the BioNumerics platform globally for its plant breeding program. The choice for BioNumerics was incentivized by the software’s comprehensive databasing and analysis tools, enabling workers to deploy one uniform software platform for diverse projects and techniques. IT managers and bioinformaticians at Bayer CropScience greatly valued the flexible scripting possibilities using Python as an instrument to integrate the BioNumerics software with existing tools and realize automatic workflows for high-throughput data management. read more
Cryo-Save Group N.V. (Euronext: CRYO, 'Cryo-Save', or 'the Group'), the leading international family stem cell bank, announces that it has incorporated a wholly owned subsidiary in Delaware, USA. The subsidiary is called Cryo-Save USA, Inc. and will commercialize and further develop the Cryo-Lip® service in North America. Cryo-Lip® allows adults to store stem cells from fat tissue which is extracted whilst undergoing other surgical procedures. read more
HIV researchers at CDC and across the globe are keeping close watch on the rapid mutations of HIV and its threat of resistance to current and novel therapies. In order to track variant, atypical and drug resistant HIV strains, smart systems are required that can rapidly process information from multiple sources into clear and reportable summarizations. Critical understanding of mutations in HIV is needed to allow physicians and public health policy makers to make treatment decisions and to create preventive measures. read more
